Takuro Kobori

536 total citations
34 papers, 438 citations indexed

About

Takuro Kobori is a scholar working on Oncology, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Takuro Kobori has authored 34 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Neurology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Takuro Kobori's work include Drug Transport and Resistance Mechanisms (11 papers), Neurofibromatosis and Schwannoma Cases (9 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Takuro Kobori is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Neurofibromatosis and Schwannoma Cases (9 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Takuro Kobori collaborates with scholars based in Japan. Takuro Kobori's co-authors include Kazuo Nakamoto, Shogo Tokuyama, Shinichi Harada, Hideo Takahashi, Atsuko Niwa, Masahiro Nishibori, Shuji Mori, Takuya Ito, Wakako Fujita‐Hamabe and Tadashi Yoshino and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Takuro Kobori

32 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuro Kobori Japan 13 164 136 76 72 55 34 438
Sophie Dithmer Germany 9 97 0.6× 280 2.1× 27 0.4× 70 1.0× 37 0.7× 9 770
J. C. Copin Switzerland 5 37 0.2× 198 1.5× 75 1.0× 73 1.0× 49 0.9× 6 522
María C. Ovejero‐Benito Spain 12 100 0.6× 205 1.5× 175 2.3× 16 0.2× 54 1.0× 29 560
Marianne N. Manjavachi Brazil 14 99 0.6× 140 1.0× 75 1.0× 37 0.5× 81 1.5× 15 605
Letizia Fornari Italy 11 73 0.4× 184 1.4× 62 0.8× 13 0.2× 42 0.8× 11 742
Tiziana Adage Austria 13 146 0.9× 202 1.5× 151 2.0× 50 0.7× 70 1.3× 27 666
Huimin Dong China 12 99 0.6× 262 1.9× 41 0.5× 76 1.1× 42 0.8× 24 533
Janet E. Holley United Kingdom 10 32 0.2× 172 1.3× 105 1.4× 30 0.4× 38 0.7× 15 425

Countries citing papers authored by Takuro Kobori

Since Specialization
Citations

This map shows the geographic impact of Takuro Kobori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuro Kobori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuro Kobori more than expected).

Fields of papers citing papers by Takuro Kobori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuro Kobori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuro Kobori. The network helps show where Takuro Kobori may publish in the future.

Co-authorship network of co-authors of Takuro Kobori

This figure shows the co-authorship network connecting the top 25 collaborators of Takuro Kobori. A scholar is included among the top collaborators of Takuro Kobori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuro Kobori. Takuro Kobori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobori, Takuro, et al.. (2025). Ezrin works as a scaffold protein for a macrophage checkpoint molecule CD47, leading to a poor prognosis for patients with uterine cervical squamous cell carcinoma. Taiwanese Journal of Obstetrics and Gynecology. 64(2). 239–247. 1 indexed citations
2.
Kurokawa, Suguru, Takuro Kobori, Masato Yoneda, et al.. (2024). Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma. BMC Gastroenterology. 24(1). 57–57. 3 indexed citations
4.
Tanaka, Rina, et al.. (2023). Study on enteral nutrient components causing decreased gastric phenytoin absorption. Journal of Parenteral and Enteral Nutrition. 47(7). 911–919.
5.
Kobori, Takuro, et al.. (2023). Moesin affects the plasma membrane expression and the immune checkpoint function of CD47 in human ovarian clear cell carcinoma. Journal of Reproductive Immunology. 161. 104185–104185. 1 indexed citations
6.
Kobori, Takuro, et al.. (2022). Ezrin Contributes to the Plasma Membrane Expression of PD–L1 in A2780 Cells. Journal of Clinical Medicine. 11(9). 2457–2457. 4 indexed citations
8.
9.
Kobori, Takuro, et al.. (2022). Ezrin and Radixin Differentially Modulate Cell Surface Expression of Programmed Death Ligand-1 in Human Pancreatic Ductal Adenocarcinoma KP-2 Cells. SHILAP Revista de lepidopterología. 2(1). 68–84. 8 indexed citations
10.
Kobori, Takuro, et al.. (2021). Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells. Molecules. 26(18). 5648–5648. 12 indexed citations
11.
12.
Kobori, Takuro, Atsuko Niwa, Takashi Nishinaka, et al.. (2018). Effects of scavenger receptors-1 class A stimulation on macrophage morphology and highly modified advanced glycation end product-protein phagocytosis. Scientific Reports. 8(1). 5901–5901. 33 indexed citations
13.
Kobori, Takuro, Takashi Nishinaka, Atsuko Niwa, et al.. (2018). Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis. Frontiers in Immunology. 9. 334–334. 54 indexed citations
14.
Niwa, Atsuko, Masahiro Nishibori, Takuro Kobori, et al.. (2015). Voluntary exercise induces neurogenesis in the hypothalamus and ependymal lining of the third ventricle. Brain Structure and Function. 221(3). 1653–1666. 43 indexed citations
15.
Kobori, Takuro, Shinichi Harada, Kazuo Nakamoto, et al.. (2014). Involvement of Moesin in the Development of Morphine Analgesic Tolerance through P-glycoprotein at the Blood-Brain Barrier. Drug Metabolism and Pharmacokinetics. 29(6). 482–489. 18 indexed citations
16.
Kobori, Takuro, Shinichi Harada, Kazuo Nakamoto, & Shogo Tokuyama. (2013). Functional Alterations of Intestinal P-Glycoprotein under Diabetic Conditions. Biological and Pharmaceutical Bulletin. 36(9). 1381–1390. 24 indexed citations
17.
Kobori, Takuro, Shinichi Harada, Kazuo Nakamoto, & Shogo Tokuyama. (2013). Time-Dependent Changes in the Activation of RhoA/ROCK and ERM/p-ERM in the Increased Expression of Intestinal P-Glycoprotein by Repeated Oral Treatment with Etoposide. Journal of Pharmaceutical Sciences. 102(5). 1670–1682. 19 indexed citations
18.
Kobori, Takuro, Shinichi Harada, Kazuo Nakamoto, & Shogo Tokuyama. (2013). Involvement of PtdIns(4,5)P2 in the Regulatory Mechanism of Small Intestinal P-Glycoprotein Expression. Journal of Pharmaceutical Sciences. 103(2). 743–751. 7 indexed citations
19.
Kobori, Takuro, Shinichi Harada, Kazuo Nakamoto, & Shogo Tokuyama. (2013). Activation of ERM-Family Proteins via RhoA-ROCK Signaling Increases Intestinal P-gp Expression and Leads to Attenuation of Oral Morphine Analgesia. Journal of Pharmaceutical Sciences. 102(3). 1095–1105. 28 indexed citations
20.
Nakamoto, Kazuo, Shintaro Kawasaki, Takuro Kobori, et al.. (2012). Involvement of matrix metalloproteinase-9 in the development of morphine tolerance. European Journal of Pharmacology. 683(1-3). 86–92. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026